ArticlemedRxiv : the preprint server for health sciences2025

Pharmacological weight loss with incretin-based therapies does not result in a disproportionate loss of muscle mass or function in obese mice and humans.

Henning Tim Langer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.